Mononuclear phagocytes in head and neck squamous cell carcinoma

Area of Science:

• Immunology
• Oncology
• Cancer Biology

Background:

• Head and neck squamous cell carcinoma (HNSCC) microenvironments are rich in immune cells.
• Mononuclear phagocytes are key immune components within the HNSCC tumor microenvironment.
• Tumor-associated inflammation, particularly involving cytokines like interleukin-6, plays a significant role in HNSCC progression.

Purpose of the Study:

• To review the complex interactions between mononuclear phagocytes and HNSCC tissue.
• To elucidate the role of inflammation and interleukin-6 in the context of HNSCC.
• To explore potential therapeutic strategies targeting mononuclear phagocytes in HNSCC.

Main Methods:

• Literature review of studies on mononuclear phagocytes in HNSCC.
• Analysis of the role of inflammation and cytokines in HNSCC pathogenesis.
• Synthesis of current knowledge on immune cell interactions within the tumor microenvironment.

Main Results:

• Mononuclear phagocytes are prevalent and influential within the HNSCC microenvironment.
• Interleukin-6 is a critical cytokine mediating inflammatory responses and potentially promoting tumor growth in HNSCC.
• Understanding these interactions is crucial for developing effective cancer therapies.

Conclusions:

• Mononuclear phagocytes and their secretory products significantly influence HNSCC.
• Targeting mononuclear phagocytes and their cytokine production presents a promising avenue for future HNSCC treatment strategies.
• Further research into immunomodulatory therapies for HNSCC is warranted.